PMID- 35239504 OWN - NLM STAT- MEDLINE DCOM- 20220405 LR - 20220531 IS - 1741-7899 (Electronic) IS - 1470-1626 (Linking) VI - 163 IP - 5 DP - 2022 Mar 24 TI - T2DM-elicited oxidative stress represses MTA3 expression in mouse Leydig cells. PG - 267-280 LID - 10.1530/REP-21-0413 [doi] AB - Metastasis-associated protein 3 (MTA3) functions as a versatile coregulator in cancers and in physiological contexts. A predominant expression of MTA3 in interstitial Leydig cells (LCs) and its role as a local modulator of testicular steroidogenesis have recently emerged. Incubation with insulin decreased MTA3 expression in a concentration- and exposure time-dependent manner in LCs. This raises the possibility of additional endocrine actions of insulin in the direct control of MTA3 expression, which remains so far unexplored. Herein, we reported that type 2 diabetes mellitus (T2DM)-mediated inhibition of MTA3 was associated with an increase in testicular oxidative stress. In contrast, a gavage of the strong antioxidant melatonin effectively ameliorated oxidative stress and restored the expression of MTA3, but failed to change serum insulin levels in the diabetic mice with testosterone deficiency (TD). Using multiple biochemical approaches, we demonstrated that oxidative stress suppressed MTA3 expression via repression of nuclear receptor subfamily 4 group A member 1 (NR4A1)-mediated transactivation of MTA3 in mouse LCs. By contrast, ectopic expression of NR4A1 ameliorated oxidative stress-impaired MTA3 expression in LCs. By employing an effective in vivo gene transfer method with microinjection of lentiviral plasmids, we showed that replenishment of MTA3 expression in vivo partially restored testicular steroidogenesis and improved male fertility in diabetic mice with TD. Thus, we have unveiled a central regulatory hub, involving oxidative stress-impaired NR4A1-driven transactivation of MTA3 in stimulated LCs, as a potential mechanism regulating crosstalk between hyperinsulinemia and male infertility associated with TD. FAU - Liu, Fei AU - Liu F AD - Department of Urology, Xijing Hospital, Air Force Medical University, Xi'an, Shaanxi Province, People's Republic of China. FAU - Chen, Zhen-Zhen AU - Chen ZZ AD - Institute of Medical Research, Northwestern Polytechnical University, Xi'an, Shaanxi Province, People's Republic of China. FAU - Zhao, Jie AU - Zhao J AD - Department of Human Anatomy, Histology and Embryology, Air Force Medical University, Xi'an, Shaanxi Province, People's Republic of China. FAU - Zhang, Yuan-Qiang AU - Zhang YQ AD - Department of Human Anatomy, Histology and Embryology, Air Force Medical University, Xi'an, Shaanxi Province, People's Republic of China. FAU - Ma, Jing AU - Ma J AD - Department of Traditional Chinese Medicine, Xijing Hospital, Air Force Medical University, Xi'an, Shaanxi Province, People's Republic of China. FAU - Li, Wei AU - Li W AUID- ORCID: 0000-0003-2487-3773 AD - Institute of Medical Research, Northwestern Polytechnical University, Xi'an, Shaanxi Province, People's Republic of China. AD - Department of Human Anatomy, Histology and Embryology, Air Force Medical University, Xi'an, Shaanxi Province, People's Republic of China. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20220324 PL - England TA - Reproduction JT - Reproduction (Cambridge, England) JID - 100966036 RN - 3XMK78S47O (Testosterone) SB - IM MH - Animals MH - *Diabetes Mellitus, Experimental/metabolism MH - *Diabetes Mellitus, Type 2 MH - Leydig Cells/metabolism MH - Male MH - Mice MH - *Neoplasms/metabolism MH - Oxidative Stress MH - Testosterone EDAT- 2022/03/04 06:00 MHDA- 2022/04/06 06:00 CRDT- 2022/03/03 17:13 PHST- 2021/10/15 00:00 [received] PHST- 2022/03/03 00:00 [accepted] PHST- 2022/03/04 06:00 [pubmed] PHST- 2022/04/06 06:00 [medline] PHST- 2022/03/03 17:13 [entrez] AID - 10.1530/REP-21-0413 [doi] PST - epublish SO - Reproduction. 2022 Mar 24;163(5):267-280. doi: 10.1530/REP-21-0413.